BR112013027006A2 - method of producing substances with supersaturated gas, transdermal delivery device thereof - Google Patents
method of producing substances with supersaturated gas, transdermal delivery device thereofInfo
- Publication number
- BR112013027006A2 BR112013027006A2 BR112013027006A BR112013027006A BR112013027006A2 BR 112013027006 A2 BR112013027006 A2 BR 112013027006A2 BR 112013027006 A BR112013027006 A BR 112013027006A BR 112013027006 A BR112013027006 A BR 112013027006A BR 112013027006 A2 BR112013027006 A2 BR 112013027006A2
- Authority
- BR
- Brazil
- Prior art keywords
- transdermal delivery
- delivery device
- gas
- methods
- producing substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8218—Gas operated
- A61M2205/8225—Gas operated using incorporated gas cartridges for the driving gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/30—Gas therapy for therapeutic treatment of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Surgical Instruments (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
método de produzir substâncias com gás supersaturado, dispositivo de distribuição transdérmica do mesmo o presente relatório descritivo revelou um dispositivo de distribuição transdérmica não invasiva que se refere geneticamente a um aparelho mecânico portátil para administração transdérmica não invasiva de gás, pequenos a grandes agentes farmacêuticos solúveis em água (hidrofílicos), vitaminas e outros agentes terapêuticos. os componentes de tais dispositivos de distribuição, métodos de produzir uma substância compreendendo uma quantidade supersaturada de um gás dissolvido bem como métodos de administrar um agente terapêutico utilizando tais dispositivos de distribuição e métodos de tratar uma doença ou condição utilizando tais dispositivos de distribuição são também revelados.The method of producing substances with supersaturated gas, the transdermal delivery device of the present disclosure has disclosed a non-invasive transdermal delivery device that refers genetically to a portable mechanical device for non-invasive transdermal delivery of gas, small to large soluble pharmaceutical agents. (hydrophilic) water, vitamins and other therapeutic agents. The components of such delivery devices, methods of producing a substance comprising a supersaturated amount of a dissolved gas as well as methods of administering a therapeutic agent using such delivery devices and methods of treating a disease or condition using such delivery devices are also disclosed. .
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2011/033060 WO2012144990A1 (en) | 2011-04-19 | 2011-04-19 | Method of producing substances with supersaturated gas, transdermal delivery thereof, and uses thereof |
US201261591443P | 2012-01-27 | 2012-01-27 | |
PCT/US2012/034316 WO2012145555A2 (en) | 2011-04-19 | 2012-04-19 | Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013027006A2 true BR112013027006A2 (en) | 2016-12-27 |
Family
ID=47042166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013027006A BR112013027006A2 (en) | 2011-04-19 | 2012-04-19 | method of producing substances with supersaturated gas, transdermal delivery device thereof |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2699306A4 (en) |
JP (1) | JP2014515666A (en) |
KR (1) | KR20140035378A (en) |
CN (1) | CN103648576A (en) |
AU (1) | AU2012245373A1 (en) |
BR (1) | BR112013027006A2 (en) |
CA (1) | CA2833851A1 (en) |
IL (1) | IL228970A0 (en) |
MX (1) | MX2013012205A (en) |
RU (1) | RU2013151160A (en) |
SG (1) | SG194215A1 (en) |
WO (1) | WO2012145555A2 (en) |
ZA (1) | ZA201307980B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10130800B2 (en) | 2012-01-27 | 2018-11-20 | Invisiderm, Llc | Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof |
CN115154882A (en) * | 2014-03-26 | 2022-10-11 | 纳诺麦德皮肤护理公司 | Substance delivery device and head |
CA3013821C (en) * | 2016-02-05 | 2022-05-10 | Clover Hill Healthcare, Inc. | Nasal treatment delivery device with carbon dioxide and saline, and methods, including low flow rates |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5851544A (en) * | 1997-12-18 | 1998-12-22 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic skin or hair care compositions containing fluorocarbons infused with carbon dioxide |
AU2001272086A1 (en) * | 2000-02-28 | 2001-09-12 | Capnia Incorporated | Method and apparatus for transcutaneous infusion of carbon dioxide for local relief of pain and other ailments |
US6723077B2 (en) * | 2001-09-28 | 2004-04-20 | Hewlett-Packard Development Company, L.P. | Cutaneous administration system |
DE20221228U1 (en) * | 2002-11-12 | 2005-07-07 | Bode, Lothar | Device used for applying substances under pressure to skin comprises main component with pressure medium container, controllable stop valve, pressure reducer and nozzle |
US7857167B1 (en) * | 2005-08-29 | 2010-12-28 | Anthony Scott Hollars | Compressed gas cartridge permeation dispenser having a predictable permeation rate |
BRPI0604018A (en) * | 2006-08-31 | 2008-08-26 | Mario Augusto Da Silva Freitas | Method and equipment combining parenteral injection of medicinal carbon dioxide (CO2) concomitantly with the application of infrared radiation from thermal and / or light sources using control by skin and / or body thermometry |
US9713570B2 (en) * | 2008-04-09 | 2017-07-25 | Respiderm Corporation | Mobile apparatus for the dispersion and transdermal delivery of pharmaceutical, medical or purified carbon dioxide gas |
WO2010073755A1 (en) * | 2008-12-26 | 2010-07-01 | 日本エー・シー・ピー株式会社 | Pressurized carbon dioxide mist bathing system |
US8118777B2 (en) * | 2009-05-29 | 2012-02-21 | Cook Medical Technologies Llc | Systems and methods for delivering therapeutic agents |
US20120116291A1 (en) * | 2009-07-14 | 2012-05-10 | Kuninobu Mogi | Device for percutaneous absorption of carbon dioxide gas, method for percutaneous absorption of carbon dioxide gas, and envelope body |
-
2012
- 2012-04-19 SG SG2013077706A patent/SG194215A1/en unknown
- 2012-04-19 AU AU2012245373A patent/AU2012245373A1/en not_active Abandoned
- 2012-04-19 EP EP12774807.7A patent/EP2699306A4/en not_active Withdrawn
- 2012-04-19 MX MX2013012205A patent/MX2013012205A/en not_active Application Discontinuation
- 2012-04-19 RU RU2013151160/14A patent/RU2013151160A/en not_active Application Discontinuation
- 2012-04-19 BR BR112013027006A patent/BR112013027006A2/en not_active Application Discontinuation
- 2012-04-19 KR KR1020137030605A patent/KR20140035378A/en not_active Application Discontinuation
- 2012-04-19 WO PCT/US2012/034316 patent/WO2012145555A2/en active Application Filing
- 2012-04-19 CN CN201280030260.2A patent/CN103648576A/en active Pending
- 2012-04-19 CA CA2833851A patent/CA2833851A1/en not_active Abandoned
- 2012-04-19 JP JP2014506557A patent/JP2014515666A/en active Pending
-
2013
- 2013-10-20 IL IL228970A patent/IL228970A0/en unknown
- 2013-10-24 ZA ZA2013/07980A patent/ZA201307980B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201307980B (en) | 2014-06-25 |
RU2013151160A (en) | 2015-05-27 |
WO2012145555A3 (en) | 2013-01-17 |
CN103648576A (en) | 2014-03-19 |
EP2699306A4 (en) | 2016-07-27 |
AU2012245373A1 (en) | 2013-11-14 |
KR20140035378A (en) | 2014-03-21 |
CA2833851A1 (en) | 2012-10-26 |
WO2012145555A2 (en) | 2012-10-26 |
MX2013012205A (en) | 2014-05-28 |
EP2699306A2 (en) | 2014-02-26 |
JP2014515666A (en) | 2014-07-03 |
IL228970A0 (en) | 2013-12-31 |
SG194215A1 (en) | 2013-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013027010A2 (en) | method of producing substances with supersaturated gas, device for their transdermal delivery, and their uses | |
AR097178A1 (en) | DIAGNOSIS AND ANTI-CANCER THERAPIES THAT INCLUDE CANCEROSE MOTHER CELLS | |
UA117103C2 (en) | Glucagon analogues | |
PH12015500407B1 (en) | Methods of treating hypertriglyceridemia | |
EA201001577A1 (en) | DPP-4 INHIBITOR IN A COMBINATION WITH AN ADDITIONAL ANTI-DIABETIC AGENT, TABLETS INCLUDING THE SPECIFIED COMPOSITIONS, THEIR APPLICATION AND METHOD OF THEIR PRODUCTION | |
BR112012023021A2 (en) | indazole compounds and their uses | |
BR112016016290A2 (en) | PHARMACEUTICAL COMPOSITIONS OF FAST-ACTING INSULIN, INFUSION SET, INFUSION SET SYSTEM AND USES OF MONOMER OR DIMERIC INSULIN ANALOGS | |
MY174727A (en) | Stable, protracted glp-1/glucagon receptor co-agonists for medical use | |
MX2013002488A (en) | Methods and compositions for delivering interleukin-1 receptor antagonist. | |
MX2021013880A (en) | Proton-binding polymers for oral administration. | |
CL2013000063A1 (en) | A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process. | |
UA111738C2 (en) | METHOD OF ACTIVE CANCER IMMUNOTHERAPY BY CANCER BY USING TUMOR CELLS DESTROYED BY HIGH HYDROSTATIC TISCODINE | |
AR095338A1 (en) | NON-TOXIC TREATMENT METHOD FOR DRUG ABSTINENCE | |
EA201001287A1 (en) | TREATMENT OF HYPERGLYCEMIA 25-HYDROXIVITAMIN D3 | |
EA201400002A1 (en) | METHODS TO TREAT DISEASES OF THE RETAIL | |
UA113962C2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING APOMORPHINE AS AN ACTIVE INGREDIENT | |
BR112014003071A2 (en) | treatment of peripheral vascular disease using umbilical cord tissue derived cells | |
BR112015004110A2 (en) | prostate drug delivery systems and methods | |
EA201491702A1 (en) | OPTIMIZED THERAPEUTIC AGENTS FOR SCRAPTURE INTRODUCTION | |
PE20181332A1 (en) | METHODS OF SEDATION AND PARENTERAL FORMULATION FOR USE DURING THE TREATMENT OF CRITICAL CARE | |
MX2020001768A (en) | Methods of treatment of osteoarthritis with transdermal cannabidiol gel. | |
EA201491258A1 (en) | Self-flashing catheters | |
EA201591450A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING GLYCOSAMINO GLYCAN | |
BR112013027006A2 (en) | method of producing substances with supersaturated gas, transdermal delivery device thereof | |
BR112012014107B8 (en) | transdermal therapeutic system (tts) and tts production process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |